{
    "title": "ESR1 Mutations in Breast Cancer",
    "abstract": "",
    "authors": [
        "Derek Dustin",
        "Guowei Gu",
        "Suzanne AW Fuqua"
    ],
    "published_year": "Not available",
    "description": "",
    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788940/",
    "doi": "https://doi.org/10.1002/cncr.32345",
    "citation_count": 96,
    "references": {
        "11011141": "Identification of Growth-Related Gene BAMBI and Analysis of Gene Structure and Function in the Pacific White Shrimp Litopenaeus vannamei",
        "10986181": "Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer",
        "10968497": "An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy",
        "10959978": "Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling",
        "10891235": "The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast",
        "10883292": "Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor\u2013positive Breast Cancer",
        "10870118": "Phase Ia/b Study of Giredestrant \u00b1 Palbociclib and \u00b1 Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor\u2013Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer",
        "10857653": "Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer",
        "10794297": "Case report: ex vivo tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinoma",
        "10767813": "KnockTF 2.0: a comprehensive gene expression profile database with knockdown/knockout of transcription (co-)factors in multiple species",
        "10718515": "Hierarchical False Discovery Rate Control for High-dimensional Survival Analysis with Interactions",
        "10706486": "Genetic Testing Enhances the Precision Diagnosis and Treatment of Breast Cancer",
        "10689793": "A deep learning model predicts the presence of diverse cancer types using circulating tumor cells",
        "10648290": "Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target",
        "10637808": "Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology",
        "10630662": "Systematic analysis of DNA methylation-mediated TF dysregulation on lncRNAs reveals critical roles in tumor immunity",
        "10611521": "The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer",
        "10572081": "Estrogen Receptor Signaling in Breast Cancer",
        "10551544": "Optimization of small molecule degraders and antagonists for targeting estrogen receptor based on breast cancer: current status and future",
        "10548240": "Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation",
        "10546685": "Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis",
        "10507584": "Delineating highly transcribed noncoding elements landscape in breast cancer",
        "10477975": "Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis",
        "10472108": "Clinical and Genomic Characteristics of Patients with Hormone Receptor\u2013Positive, Human Epidermal Growth Factor Receptor 2\u2013Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors",
        "10438957": "Cobind: quantitative analysis of the genomic overlaps",
        "10426190": "SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER\u2009+\u2009breast cancer models",
        "10311893": "MRI-based breast cancer radiogenomics using RNA profiling: association with subtypes in a single-center prospective study",
        "10297184": "Development of a Detection System for ESR1 Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping",
        "10296317": "Acute Myeloid Leukemia Expresses a Specific Group of Olfactory Receptors",
        "10295144": "Study of Liquid-Based Cytology Using Next-Generation Sequencing as a Liquid Biopsy Application in Patients with Advanced Oncological Disease",
        "10284573": "An efficient and effective method to identify significantly perturbed subnetworks in cancer",
        "10251337": "The future of cancer immunotherapy: DNA vaccines leading the way",
        "10206440": "Modeling breast cancer proliferation, drug synergies, and alternating therapies",
        "10178988": "Clinical and Translational Applications of Serological and Histopathological Biomarkers in Metastatic Breast Cancer: A Comprehensive Review",
        "10163076": "Tumor Molecular Profiling in Hispanics: Moving Towards Precision Oncology and Health Equity",
        "10116798": "Regulation of ER\u03b1-dependent breast cancer metastasis by a miR-29a signaling",
        "10095386": "A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer",
        "10093251": "Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer",
        "9959993": "Targeting Breast Cancer: An Overlook on Current Strategies",
        "9954687": "Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer",
        "9954458": "CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients",
        "9915613": "EstroGene database reveals diverse temporal, context-dependent and directional estrogen receptor regulomes in breast cancer",
        "9889408": "Estrogen receptor \u03b1 K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin opening",
        "9878779": "Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry",
        "9831673": "Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants",
        "9827653": "Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study",
        "9804579": "Common genetic variants associated with melanoma risk or naevus count in patients with wildtype  MC1R  melanoma",
        "9438742": "Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer",
        "9424154": "Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer",
        "9265113": "Breast Cancer Genomics: Primary and Most Common Metastases",
        "9234971": "Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer",
        "9208078": "Integrated multi\u2010omics profiling of high\u2010grade estrogen receptor\u2010positive, HER2\u2010negative breast cancer",
        "9140186": "Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells",
        "9036337": "Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer",
        "9033346": "Screening of Immune-Related Genes and Predicting the Immunotherapeutic Effects of Formononetin in Breast Cancer: A Bioinformatics Analysis",
        "9006609": "Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ER\u03b1 expression and proliferation in luminal primary and metastatic breast cancer cells",
        "8960645": "Identification of Epigenetically Modified Hub Genes and Altered Pathways Associated With Retinoblastoma",
        "8959467": "Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis",
        "8952417": "Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach",
        "8913656": "Systematic understanding of anti-tumor mechanisms of Tamarixetin through network and experimental analyses",
        "8809934": "Exploring anti-liver cancer targets and mechanisms of oxyresveratrol: in silico and verified findings",
        "8806317": "Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer",
        "8801958": "Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer",
        "8773730": "Role of ctDNA in Breast Cancer",
        "8749083": "Immune response pathways enriched in breast cancer samples with brain metastasis",
        "8699146": "Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer",
        "8582464": "Resistance Mechanisms to Combined CDK4/6 Inhibitors and Endocrine Therapy in ER+/HER2\u2212 Advanced Breast Cancer: Biomarkers and Potential Novel Treatment Strategies",
        "8560682": "Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics",
        "8535095": "Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer",
        "8531720": "Peritoneal Metastasis After Treated With Abemaciclib Plus Fulvestrant for Metastatic Invasive Lobular Breast Cancer: A Case Report and Review of the Literature",
        "8525510": "Progesterone and Progesterone Receptors in Breast Cancer: Past, Present, Future",
        "8488784": "Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases",
        "8480308": "Nuclear Mechanisms Involved in Endocrine Resistance",
        "8443188": "NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers",
        "8414389": "A review of the endocrine resistance in hormone-positive breast cancer",
        "8268401": "Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer",
        "8241852": "The effect of protein mutations on drug binding suggests ensuing personalised drug selection",
        "8172429": "Genomic, Transcriptomic and Proteomic Profiling of Metastatic Breast Cancer",
        "8112962": "Effective Material Basis and Mechanism Analysis of Compound Banmao Capsule against Tumors Using Integrative Network Pharmacology and Molecular Docking",
        "8104980": "Advances in Therapy for Hormone Receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer Patients Who Have Experienced Progression After Treatment with CDK4/6 Inhibitors",
        "8060794": "Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer",
        "8053190": "NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU",
        "7962645": "The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer",
        "7859793": "Profiles of alternative splicing landscape in breast cancer and their clinical significance: an integrative analysis based on large-sequencing data",
        "7782501": "RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer",
        "7770162": "Detection of ESR1 Mutations Based on Liquid Biopsy in Estrogen Receptor-Positive Metastatic Breast Cancer: Clinical Impacts and Prospects",
        "7732281": "Pharmacological targets and mechanisms of calycosin against meningitis",
        "7572750": "Targeting the PI3K/AKT/mTOR Pathway in Hormone Positive Breast Cancer",
        "7531252": "Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer",
        "7436992": "Clinical implications of prospective genomic profiling of metastatic breast cancer patients",
        "7310532": "New generation breast cancer cell lines developed from patient-derived xenografts",
        "7299846": "Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer",
        "7226513": "Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells",
        "7213629": "Advances in endocrine and targeted therapy for hormone-receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer",
        "7152560": "Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer",
        "6943351": "ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future"
    },
    "journal": "Cancer",
    "topics": [
        "breast, cancer, mutations",
        "mutations, cancer, breast",
        "breast, mutations, cancer"
    ]
}